EP Patent

EP1933856A4 — Method for treatment or prevention of conditions caused by gram-positive bacteria

Assigned to SEPSICURE LLC · Expires 2008-11-19 · 17y expired

What this patent protects

The treatment, prevention and prophylaxis of conditions such as sepsis, septic shock, systemic inflammatory response syndrome or 'SIRS', SIRS with organ dysfunction or failure, organ failure and organ dysfunction are described. These conditions are associated with infection by Gr…

USPTO Abstract

The treatment, prevention and prophylaxis of conditions such as sepsis, septic shock, systemic inflammatory response syndrome or 'SIRS', SIRS with organ dysfunction or failure, organ failure and organ dysfunction are described. These conditions are associated with infection by Gram-positive bacteria. The treatment involves the administration of compositions containing a phospholipid, a neutral lipid, and a bile acid or a bile acid salt.

Drugs covered by this patent

Patent Metadata

Patent number
EP1933856A4
Jurisdiction
EP
Classification
—
Expires
2008-11-19
Drug substance claim
No
Drug product claim
No
Assignee
SEPSICURE LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.